Is Surrogacy Modern-Day Slavery? What to Know About Florida Republican Effort to Pass Severe Restrictions.

Key Takeaways

• AG Uthmeier argues surrogacy violates Florida constitution, labeling it slavery
• DeSantis-backed bill bans surrogacy contracts with nationals from China, Iran, Cuba
• Court ruling could extend beyond surrogacy to IVF and abortion regulations
• Restriction reflects Florida's broader push to limit foreign influence in reproductive law

Pulse Analysis

Surrogacy has become a fast‑growing segment of the U.S. reproductive‑technology market, with estimates that more than 5,000 babies are born each year through gestational carriers. In Florida, the practice has traditionally been governed by a 2019 statute that permits contracts between intended parents and surrogate mothers, provided certain medical and ethical safeguards are met. The latest twist comes from Attorney General James Uthmeier, who has filed an appeal arguing that the state constitution implicitly prohibits surrogacy, equating it with modern‑day slavery. His challenge now sits before the Fourth District Court of Appeal, putting the state's most permissive surrogacy framework on uncertain footing.

The legal fight dovetails with a broader legislative push led by Governor Ron DeSantis to tighten Florida's reproductive‑law landscape. Earlier this year lawmakers passed a bill that bars residents of designated “countries of concern”—including China, Iran and Cuba—from entering into surrogacy agreements. Framed as a safeguard against foreign influence, the measure is part of a sweeping agenda that targets academic institutions, media outlets and technology firms. Critics argue the provision discriminates against legitimate international families and could drive intended parents to seek contracts in more permissive states, undermining Florida’s reputation as a biotech hub.

If Uthmeier succeeds, the ramifications could ripple far beyond surrogacy. Florida’s courts may interpret his constitutional argument to restrict other assisted‑reproductive technologies such as in‑vitro fertilization, which already faces scrutiny after a separate Supreme Court ruling on embryo rights. The precedent could also embolden anti‑abortion legislators to invoke similar language, further constraining reproductive autonomy. Industry groups are watching closely, warning that a hostile regulatory climate could deter investment in fertility clinics and related research. The outcome will likely serve as a bellwether for how state governments balance bioethical concerns with market‑driven innovation.